Evidence map›Paper›PMID 34660499›Full record

ReviewFrontiers in public health2021

Social Non-profit Bioentrepreneurship: Current Status and Future Impact on Global Health.

Amir H Sadeghi, Charlotte Koldeweij, Grissel Trujillo-de Santiago, Milad Tannazi, Nikkie Hosseinnia, Oscar van Loosbroek, Amir Manbachi, Yannick J H J Taverne, Ad J J C Bogers, Mario Moisés Alvarez

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amir H SadeghiBiomaterials Innovation Research Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States.
Charlotte KoldeweijDepartment of Medicine, Utrecht University, Utrecht, Netherlands.
Grissel Trujillo-de SantiagoBiomaterials Innovation Research Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States.
Milad TannaziAvicenna Foundation, Avicenna Excellence Program, Utrecht, Netherlands.
Nikkie HosseinniaDepartment of Pharmaceutical Science, Utrecht University, Utrecht, Netherlands.
Oscar van LoosbroekDepartment of Pharmaceutical Science, Utrecht University, Utrecht, Netherlands.
Amir ManbachiBiomaterials Innovation Research Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States.
Yannick J H J TaverneDepartment of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
Ad J J C BogersDepartment of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
Mario Moisés AlvarezBiomaterials Innovation Research Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States.

Funding

Institutional Career Development CoreKL2TR003099 · NCATS · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2019 to 2023
$7.9M
NCATS NIH HHS KL2 TR003099
6 · The paper itself

Abstract

For-profit biotechnological and pharmaceutical companies have played an essential role in the research and development (R&D) of innovative medical products and drugs for many decades and embody a trillion-dollar industry. The past decades have been marked by an increase in growth of social non-profit biotechnology companies and organizations led by entrepreneurs committed to solve (global) health issues. In this review, we define the concept of social bioentrepreneurship and consider the potential impact of such ventures on global health. We analyse the current status of non-profit biotechnology and clarify the strategy, motivation, funding, and marketing techniques of these enterprises. We find that these non-profit ventures mainly focus on neglected and rare diseases by using different but also similar funding, marketing, and business strategy approaches to for-profit biotechnology enterprises. We also identify good leadership, multidisciplinary teams, and public awareness as key components to achieve long-term survival and higher success rates. Challenges faced by bioentrepreneurs include the lack of a clearly defined regulatory environment or governmental incentives to support their endeavors. Overall, with this qualitative data review and market analysis we draw a promising picture of social non-profit bioentrepreneurship and underscore its current and future impact on global health issues.

Indexed as

Global HealthOrganizations, NonprofitBiotechnologyCommerceaffordabilitybioentrepreneurshipbiotechnologyentrepreneurshipglobal healthnon-profitsocial entrepreneurship

Identifiers

PMID34660499
PMCPMC8517255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.